AUTHOR=Lu Qiaoqiao , Lai Jianbo , Lu Haifeng , Ng Chee , Huang Tingting , Zhang Hua , Ding Kaijing , Wang Zheng , Jiang Jiajun , Hu Jianbo , Lu Jing , Lu Shaojia , Mou Tingting , Wang Dandan , Du Yanli , Xi Caixi , Lyu Hailong , Chen Jingkai , Xu Yi , Liu Zhuhua , Hu Shaohua TITLE=Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: An Advanced Exploration JOURNAL=Frontiers in Psychiatry VOLUME=10 YEAR=2019 URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.00784 DOI=10.3389/fpsyt.2019.00784 ISSN=1664-0640 ABSTRACT=
The mechanism of bipolar disorder is unclear. Growing evidence indicates that gut microbiota plays a pivotal role in mental disorders. This study aimed to find out changes in the gut microbiota in bipolar depression (BD) subjects following treatment with quetiapine and evaluate their correlations with the brain and immune function. Totally 36 subjects with BD and 27 healthy controls (HCs) were recruited. The severity of depression was evaluated with the Montgomery-Asberg depression rating scale (MADRS). At baseline, fecal samples were collected and analyzed by quantitative polymerase chain reaction (qPCR). T lymphocyte subsets were measured to examine immune function. Near-infrared spectroscopy (NIRS) was used to assess brain function. All BD subjects received quetiapine treatment (300 mg/d) for four weeks, following which the fecal microbiota and immune profiles were reexamined. Here, we first put forward the new concept of brain-gut coefficient of balance (B-GCB), which referred to the ratio of [oxygenated hemoglobin]/(